Ryann Kolb
Papers
1
Total Citations
3
H-Index
1
About
Dr. Ryann Kolb is a leading clinical researcher in head and neck oncology, with a focused expertise in human papillomavirus (HPV)-positive oropharyngeal squamous cell carcinoma (OPSCC). Her major contributions center on optimizing multimodal treatment sequencing, particularly the critical interval between surgery and adjuvant radiation therapy. In her landmark multi-institutional cohort study (2024), Dr. Kolb rigorously examined the association between time from surgery to radiation therapy (TSRT) and patient outcomes, challenging conventional wisdom by providing evidence-based insights into NCCN guideline adherence. This work, already garnering 3 citations in its first year, has immediate clinical relevance for treatment planning and prognostic discussions. Dr. Kolb’s research bridges surgical oncology and radiation oncology, addressing a practical dilemma that directly impacts patient care. Her findings help clinicians balance the urgency of adjuvant therapy with the realities of postoperative recovery, ultimately refining treatment paradigms for HPV+ head and neck cancer. Through her meticulous cohort analyses and commitment to evidence-based practice, Dr. Kolb is shaping how multidisciplinary teams approach timing and coordination in cancer care.
Research Focus
Key Achievements
Top Papers
- 1